👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Cathie Wood's ARK buys Tempus AI stock, sheds Senti Biosciences

Published 12/10/2024, 09:02 AM

Cathie Wood's ARK ETF published their daily trades for Monday, December 9th, 2024, revealing a notable shift in their investment strategy. The largest transaction of the day was a significant purchase of Tempus AI Inc (NYSE:TEM) shares, totaling 84,045 across the ARKK and ARKG ETFs, amounting to a dollar value of approximately $4,239,229. This move indicates a continuation of ARK's recent accumulation trend in Tempus AI, following substantial buys of the stock in previous days.

The ARK team also decided to offload shares in two other companies. The ARKG ETF parted with 1,058 shares of Senti Biosciences Inc (NASDAQ:SNTI), valued at $5,819. This sale follows a pattern of reducing their position in Senti Biosciences, as seen with consistent selling throughout the past week. Additionally, ARK reduced their holdings in Markforged Holding Corp (NYSE:MKFG), selling 414 shares through the ARKQ and ARKX (NYSE:ARKX) ETFs for a total of $1,589.

The recent trading pattern reveals ARK's growing confidence in Tempus AI, as they have been steadily increasing their stake in the company, while simultaneously trimming positions in other biotech and technology stocks. Investors following ARK's trades might interpret these actions as an optimistic outlook on Tempus AI's future performance and a strategic reallocation of assets within ARK's innovative technology and healthcare-focused portfolios.

These daily trade reports offer a transparent look into the ARK ETFs' trading activities and provide investors with insights into Cathie Wood's investment strategies. As the ETFs adjust their holdings, market watchers will be keen to see how these decisions play out in the dynamic landscape of tech and biotech investments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.